IL6 and myeloid sarcoma: In MS patients, generic GA suppressed IL-6 production by DCs only at a concentration of 200 μg/ml (Fig 4C), while in healthy subjects at concentrations of 100 μg/ml and 200 μg/ml (Fig 4D).